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Selenium is an essential micronutrient required for cellular antioxidant systems, yet at higher 
doses it induces oxidative stress.   Additionally, in vertebrates environmental exposures to toxic 
levels of selenium can cause paralysis and death.  Here we show that selenium-induced oxidative 
stress leads to decreased cholinergic signaling and degeneration of cholinergic neurons required 
for movement and egg-laying in Caenorhabditis elegans.  Exposure to high levels of selenium 
leads to proteolysis of a soluble muscle protein through mechanisms suppressible by two 
pharmacological agents, levamisole and aldicarb which enhance cholinergic signaling in muscle.  
In addition, animals with reduction-of-function mutations in genes encoding post-synaptic 
levamisole-sensitive acetylcholine receptor subunits or the vesicular acetylcholine transporter 
developed impaired forward movement faster during selenium-exposure than normal animals, 
again confirming that selenium reduces cholinergic signaling.  Finally, the antioxidant reduced 
glutathione, inhibits selenium-induced reductions in egg-laying through a cellular protective 
mechanism dependent on the C. elegans glutaredoxin, GLRX-21.  These studies provide 
evidence that the environmental toxicant selenium induces neurodegeneration of cholinergic 
neurons through depletion of glutathione, a mechanism linked to the neuropathology of 
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1.  Introduction 
Selenium (Se) is an essential micronutrient that has been shown to improve the outcome of 
several models of neurodegenerative disorders (van Eersel et al., 2010; Ishrat et al., 2009; Wood-
Allum et al., 2006; Zafar et al., 2003) and has been examined in treatment paradigms for human 
disease (Fairweather-Tait et al., 2011). These studies and others (Bellinger et al., 2009) aimed at 
elucidating the functions of the many selenoproteins that incorporate Se in the form of the amino 
acid selenocysteine, have demonstrated that Se is both absorbed by the central nervous system 
(Schweizer et al., 2004) and required for muscle function (Rederstorff et al., 2006). Not 
surprisingly, it is these same two systems which have been observed to be affected in both 
animals and humans after toxic Se exposures (Koller and Exon, 1986). Chicks exposed in vivo to 
toxic levels of sodium selenite, an inorganic form of Se, experienced paralysis and died from 
respiratory failure which in vitro studies suggested resulted in part, from both sustained muscle 
contracture and blockade of presynaptic neuromuscular transmission (Lin-Shiau et al., 1990). 
Humans poisoned with high doses of Se exhibited muscle weakness prior to cardiovascular 
collapse and death (Spiller and Pfiefer, 2007) and showed evidence of neurological decline 
(Koller and Exon, 1986). Isolated populations chronically exposed to Se in their environment 
were reported to have an increased risk of developing Amyotrophic Lateral Sclerosis (ALS), a 
neuromuscular disease typified by progressive muscle weakness, paralysis, and death (Vinceti et 
al., 2010). Similarly, in the soil nematode Caenorhabditis elegans, high dose Se exposure 
induced a progressive movement impairment culminating in an irreversible paralysis phenotype 
and death (Morgan et al., 2010) that parallels the progressive decline observed with ALS. This 
suggests that Se may similarly be targeting the worm neuromuscular system. 




 The coordinate regulation of the 95 body wall muscles in C. elegans is controlled by 70 
motor neurons whose cell bodies are positioned along the ventral nerve cord and that function to 
affect a normal sinusoidal wave pattern of movement (Duerr et al., 2008; de Bono and Maricq, 
2005). Two of the major neurotransmitters conserved in C. elegans, acetylcholine and gamma-
aminobutyric acid respectively provide the excitatory and inhibitory inputs for forward and 
backward movement (Duerr et al., 2008; McIntire et al., 1993). Reduction-or loss-of-function 
mutations in genes affecting these neurotransmitter systems can result in uncoordinated 
movement behaviors (Brenner, 1974) which phenocopy many aspects observed in animals after 
Se-exposure including the inability to complete a normal backwards or forwards wave pattern, 
and paralysis (Morgan et al., 2010). One of the major advantages of using C. elegans as a model 
organism is the ability to directly correlate these behavioral changes to pathological changes in 
muscles and/or neurons that can be easily observed in vivo or in situ due to the clear body plan of 
the animal (Dimitriadi and Hart, 2010; Silverman et al., 2009).  
In order to determine how high dose Se exposure leads to motility impairment in worms, 
we began a systematic examination of both the nervous and muscular systems after high dose Se-
exposure to determine the pathological changes induced by this toxicant metalloid. Previously 
we defined a model for selenium-induced toxicity in Caenorhabditis elegans showing that 
selenium similarly induces motor impairment and increases mortality. Here we demonstrate that 
selenium exerts these effects by damaging cholinergic motor neurons and reducing their 
secretion of acetylcholine. This alters the ability of muscles to respond to environmental stimuli 
and affects two motor behaviors essential for survival, movement and egg-laying. This model is 
of particular significance because it addresses both how environmental toxins such as selenium 




induce changes in motor behaviors and provides a possible explanation for the link between 
exposures and neurodegenerative disease processes.   
 
2.  Materials and Methods 
2.1 Strains, maintenance, and growth conditions. 
The C. elegans N2 Bristol strain was used in all experiments requiring WT animals. In addition, 
the following strains were used: BL5717 inIs179[Pida-1::gfp]II;him-8(e1489)IV, CB193 unc-
29(e193)I, CB211 lev-1(e211)IV, CB382 unc-49(e382)III, CB904 unc-38(e264)I, CB993 unc-
17(e245)IV, CB1331 unc-17(e245)IV;snb-1(e1563)V, NC571 wdIs20[Punc-4::snb-1::gfp](Hung 
et al., 2007), OM316 inIs179[Pida-1::gfp]II;glrx-21(tm2921)III, PD55 tra-3(e1107)IV;ccIs55 
[Punc-54::unc-54::lac Z;sup-7(st5)]V, PJ727 ccIs55;jIs01[Pmyo-3::gfp::myo-3;rol-
6(su1006)](Fostel et al., 2003), RB918 acr-16(ok789)V, RB756 gar-2(ok520)III, VC731 unc-
63(ok1075)I, VZ54 glrx-21(tm2921)III. 
       Animals were maintained on modified NGM agar plates (Estevez et al., 2004), and 
assayed as described previously (Morgan et al., 2010), except where noted. Mock-exposure 
plates had a volume of water added which was equivalent to that added to the experimental 
plates. Eserine salicylate salt (Sigma, St. Louis, MO) was diluted in distilled water to the final 
concentrations indicated and was added to plates along with Se.  Se concentration was 5 mM 
Na2SeO3.     
2.2 Behavioral assays. 
 Assays for movement were as described (Morgan et al., 2010) unless indicated below. Many of 
the following assays included analysis of movement prior to and/or following additional 




treatments or studies. 
 2.2a Levamisole-induced hyper-contraction.  
   After 24 hours of Se exposure, fifteen paralyzed animals were picked and placed onto 
fresh agar plates containing a final concentration of 100 mM levamisole. Fifteen mock-exposed 
normal animals were similarly treated. Animals were treated with levamisole for 30 minutes then 
examined for shortening of body length and mass egg release, indications of hyper-contraction of 
the body wall and vulval muscles, respectively (Trent et al., 1983; Lewis et al., 1980).   
 2.2b Aldicarb-induced paralysis.  
  To test for resistance to aldicarb, 20 animals that failed to back after 24 hour exposure 
to Se, and 20 age-synchronized mock-exposed animals were placed on plates containing a final 
concentration of 0.5 mM aldicarb (Nonet et al., 1998).  These animals were assayed for forward 
movement every 30 minutes for a total of two hours and the number of paralyzed animals was 
scored.   
 2.2c Forward Movement. 
   Animals containing mutations in genes affecting pre- and post-synaptic inputs along the 
NMJ, and WT-N2 animals, were scored for forward movement only since mutations in some of 
the genes result in backing defects (Hosono and Kamiya, 1991). Thus, the “% forward” category 
includes backing deficient animals.   
 2.2d Egg-laying assay.  
  Populations of animals were exposed to Se or mock-exposed for one to six hours at 
25°C. At one hour intervals, ten animals were removed from each plate and placed on a 
“recovery” plate which contained no added Se.  After 24 hours, the adult animals were removed 
and the total number of eggs and hatched progeny counted. The number of eggs laid/animal/hour 




was calculated by dividing the number of eggs and progeny counted on each plate by the number 
of adult animals originally plated (n =10), and the number of hours (1-6 hrs.) they were 
incubated before moving to the recovery plate. Since the six hour time point showed the greatest 
difference between Se exposed and unexposed animals, subsequent egg-laying experiments were 
performed at this time point only.  
  Serotonin (5-hydroxytrptamine-hydrochloride, Spectrum Chemical, Gardena, CA) was 
freshly diluted in distilled water prior to assay, and added to agar plates to a final concentration 
of 3 mg/ml (serotonin plates). Adult animals were exposed to Se or mock-exposed to water for 
six hours then transferred to plates with serotonin or an equal volume of carrier (water) (three 
animals/plate). After one hour the adult animals were removed and the eggs/plate were counted.  
The rate of egg-laying was calculated from three plates/condition. 
  The comparisons between the WT and the glrx-21(tm2921) mutant strains were as above, 
except as follows. To pretreat with GSH (L-glutathione reduced, Sigma, St. Louis, MO), 
synchronized late larval stage (L4) animals were placed on agar plates with 3 mM GSH 
overnight. The next day these pretreated young adults and age matched controls, were placed on 
agar plates with or without added Se for six hours, and then moved to recovery plates for 24 
hours. Five animals from each recovery plate were placed onto four “egg-lay” plates/condition 
(e.g. control, GSH pretreatment, etc.) and allowed to lay eggs for a total of three hours before 
being removed. This assay was repeated four times totaling 16 plates/condition. 
2.3 Staining for β–galactosidase activity.  
Animals expressing the E. coli lacZ reporter gene fused in-frame to 5’ and 3’ sequences of the C. 
elegans major muscle myosin heavy chain gene, unc-54 were histochemically stained for β–
galactosidase activity as described (Szewczyk et al., 2000). 




2.4 Staining for filamentous (F)-actin.  
Animals exposed to Se or mock-exposed for either 24 or 48 hours were treated to two to three 
freeze/thaw cycles to crack their cuticles then fixed overnight at 4°C in a solution of 4% 
formaldehyde (doi/10.1895/wormbook.1.105.1). The fixed animals were washed three times in 
1x phosphate buffered saline (PBS; doi/10.1895/wormbook.1.105.1) then placed in a solution of 
Alex Fluor-594-phalloidin (Invitrogen, Carlsbad, CA) diluted to 0.2 mU/µl in 1xPBS for 24-48 
hours at 4°C followed by three to four washes with 1 x PBS/1% tritonX-100. Animals were 
stored in Vectashield mounting medium (Vector Laboratories, Burlingame, CA) until visualized. 
2.5 Cell counting. 
In order to count the number of VC neurons expressing Pida-1::gfp, adult animals expressing the 
construct were Se-exposed or mock-exposed for a total of 48 hours. After 24 hours, an average 
50 each of: mock-exposed animals, Se-exposed normal forward moving, and Se-exposed 
paralyzed animals were examined on a Leica MZ16FA dissecting stereomicroscope equipped 
with epifluorescence (Leica Microsystems Inc., Buffalo Grove, IL) and utilizing a GFP filter. 
The number of VC neuron cells per animal was scored with each animal removed from the plate 
after counting. Since mortality is directly proportional to time of Se exposure (Morgan et al., 
2010), in some instances <50 each of the paralyzed or normal moving animals were left alive on 
the Se-exposed plates; in those cases all living animals were counted. Additional sets of animals 
were counted at 48 hours. The experiment was repeated three times for strain OM316 and six 
times for strain BL5717 at both 24 and 48 hours.  Because VC neuron loss was observed in a 
small percentage of the mock-exposed animals at both 24 and 48 hours, the percentage of Se-
exposed animals with VC neuron loss was normalized to this data. This was achieved by 
subtracting the percentage of mock-exposed animals with VC neuron loss from the percentage of 




Se-exposed animals with VC neuron loss at the same time points (i.e. 51.8% of Se-exposed 
animals had VC neurons missing after 24 hours.  The VC neuron loss for the mock-exposed 
animals at 24 hours  was 1.6%, thus the normalized Se-exposed 24 hour data presented in Table 
1 = 51.8 – 1.6 = 50.2%).   
2.6 Fluorescence imaging. 
 Individual animals were visualized on an Olympus BX51 microscope equipped with 
epifluorescence (Olympus America Inc., Center Valley, PA) and utilizing a FITC (GFP) or 
Texas Red filter (phalloidin). Images were documented with a QImaging Retiga 1300 camera 
and imaging system (QImaging, Surrey, British Columbia, Canada) and processed for 
publication using Adobe CS5 Software (Adobe Systems Inc., San Jose, CA). 
2.7 Statistical analysis. 
 Statistical analysis was performed using Excel 2010 with Analysis Toolpak (Microsoft, Seattle, 
WA). The averages and standard error of means (SEM) reported were calculated from data 
obtained from all the plates of each strain or population type (e.g. treated or untreated) counted. 
P values were determined by applying one-way or two-way ANOVA analysis across populations 
followed by post-hoc analysis using two tailed Student’s t-test (to avoid an error of the first kind) 
or by Student’s t-test only. All Student’s t-tests were two-tailed with unequal variance. Graphs 
were initially drawn with Excel and were prepared for publication using Adobe Illustrator CS5.   
 
3. RESULTS 
3.1 Selenium does not disrupt muscle structure in C. elegans.  




The C. elegans musculature consists of two major types, the body wall and pharyngeal muscles 
which respectively mediate movement and feeding behaviors, as well as minor muscle groups 
involved in egg-laying (vulval and uterine), intestinal contraction, defecation and mating 
(Moerman and Fire, 1997). Exposure to the anthelmintic levamisole has been reported in C. 
elegans to cause rapid paralysis due to hyper-contraction of body wall muscles (Lewis et al., 
1980) and to induce egg-laying due to contraction of vulval muscles in wild-type (WT) animals 
(Trent et al., 1983). If the Se-induced progressive movement deficits previously reported 
(Morgan et al., 2010) resulted from significant damage to muscles, then we hypothesized that 
animals paralyzed by Se-exposure would not hyper-contract or lay eggs in response to 
levamisole treatment. This did not prove to be the case. Although all mock-exposed animals 
were able to leave a 1 cm circle 5 minutes after being placed within it (Fig. 1A-B), paralyzed 
animals exposed for 24 hours to Se did not (Fig. 1C-D). Yet, despite this difference, both mock-
exposed and Se-exposed animals showed no difference in their responses to levamisole, i.e. both 
exhibited a shortening of body length (i.e. hyper-contraction of body wall muscles; compare 
Figs. 1E and 1G to 1F and 1H, respectively), and induction of egg-laying (Fig. 1F and 1H, insets) 
suggesting that the muscles were not damaged by Se exposure. Further support of this 
assumption comes from microscopic examination of the myosin and F-actin filaments of body 
wall and vulval muscles of mock-exposed (Fig. 2A and 2C, respectively) and Se-exposed 
animals (Fig. 2B and 2D, respectively) where no detectable difference in their structural integrity 
was observed after 48 hours of exposure, a time point when less than 20% of the animals were 
previously shown to exhibit normal movement behavior (Morgan et al., 2010). These data 
together suggest that in animals exposed to Se, both the body wall and egg-laying muscles were 
still functionally and structurally intact.   




3.2  Selenium induces neuronal damage and degeneration in C. elegans.  
Since our examination of both body wall and vulval muscles after Se-exposure could not detect 
any damage, we next focused our investigation on whether injury to neurons resulted in the 
observed Se-induced deficits. In order to explore this possibility, we compared expression of the 
green fluorescent protein (GFP) under the control of the promoter for the ida-1 gene (Zahn et al., 
2001) in mock- and Se-exposed animals. The neuroendocrine protein IDA-1 is expressed in 
about 30 neurons in adult hermaphrodites including eight motor neurons (Zahn et al., 2001): the 
six VC neurons which lie along the ventral cord and innervate both body wall and vulval muscles 
(White et al., 1986), and the two hermaphrodite specific neurons (HSNs) which are required for 
egg-laying (Desai et al., 1988). In mock-exposed WT animals, all six VC neurons were observed 
under lower power magnification (200x; Fig. 2E, white arrowheads) to be present in over 98% of 
animals (Table 1) while with Se-exposure greater than 50% of the animals were missing one or 
more of these neurons after 24 hours (Table 1, 24 hours; Fig. 2F, black arrowhead).  As reported 
previously (Morgan et al., 2010), the percentage of animals with motility impairment behavior 
proportionally increased with exposure time. Yet this was not the case for VC neuron cell loss, as 
the percentage of WT animals with missing cells did not increase significantly after an additional 
24 hours of exposure time (p = 0.24; Student’s t-test comparing 24 to 48 hour Se-exposed WT 
animals). This was also true when comparing only animals with the most severe phenotype of 
paralysis, i.e. no significant difference was observed between the two time points (p = 0.28, 
Student’s t-test comparing paralyzed 24 to 48 hour Se-exposed WT animals). 
  Previous studies showed that the GLRX-21 glutaredoxin is required to prevent Se-
induced oxidative stress and that animals lacking the protein are more sensitive to Se’s effects on 
motility than are WT animals (Morgan et al., 2010). Given the role of the VC neurons in 




movement behavior, we predicted that animals lacking the GLRX-21 protein would show a 
significantly increased percentage of animals with cell loss in response to Se-exposure. 
Consistent with this hypothesis, we observed that glrx-21(tm2921) animals expressing the Pida-
1::gfp construct were one and a half times more likely than WT animals to be missing a cell after 
48 hours of Se-exposure although no significant difference was observed between the two strain 
at the 24 hours exposure time (Table 1). The additional observation that mock-exposed glrx-
21(tm2921) animals were nearly four times more likely than WT animals to be missing one or 
more VC neurons after 24 hours (Table 1) may partially explain why glrx-21(tm2921) animals 
are more sensitive to the effects of Se on movement (Morgan et al., 2010).  No difference was 
observed between the two mock-exposed strains after 48 hours (Table 1). 
 Since paralysis occurs prior to death and is the most severe movement behavior observed 
with high-dose Se-exposure (Morgan et al., 2010), we examined paralyzed animals for direct 
anatomical evidence of neuronal injury after 24 hours Se-exposure under higher magnification 
(400X; Fig. 2H, 2J) and compared them to mock-exposed age matched animals (Fig. 2G, 2I). 
Nuclear boundary loss (Fig. 2H, VC and HSN) and cellular fragmentation (HSN-Fig. 2H inset) 
were apparent in the Se-exposed paralyzed animals expressing the Pida-1::gfp transgene, but not 
in the mock-exposed animals  (Fig. 2G, 2G inset). Additional evidence of neuronal degeneration 
in Se-exposed animals was observed along the ventral cord and included axonal beading 
identified in animals expressing the Pida-1::gfp transgene (Fig. 2H, white lines), as well as an 
irregular pattern of presynaptic densities detected in animals expressing a synaptobrevin (SNB-1) 
GFP fusion protein (Fig. 2J). This disruption of the SNB-1::GFP pattern was significantly 
increased (p = 4.0 x 10
-3
) when comparing populations of Se-exposed [51.3(+4.6)%] to mock-
exposed animals [19.2(+1.4)%]. Together, these studies suggest that high dose Se-exposure 




induces damage to and loss of motor neurons in C. elegans that is consistent with the observed 
movement deficits reported previously (Morgan et al., 2010).  
3.3  Muscles in animals exposed to selenium receive less cholinergic signal.  
We used an in vivo assay that detects changes in cholinergic signaling through the activity of a 
soluble myosin-β-galactosidase fusion protein that is stably expressed in both anterior and 
posterior body wall, and vulval muscles in fed normal animals, but lost in all the posterior body 
wall muscles after starvation (Szewczyk et al., 2000). This reduction in protein stability upon 
starvation was shown to be due to reduced cholinergic signaling across the neuromuscular 
junction (NMJ) (Szewczyk et al., 2000). After just 24 hours of Se-exposure, the β-galactosidase 
activity was reduced in all muscles and was lost completely after 48 hours when compared to the 
age matched mock-exposed controls (Fig. 3A, upper panel). This pattern of activity loss is 
similar to that described for starved acetylcholine (ACh) deficient animals (Szewczyk et al., 
2000) suggesting that cholinergic signaling is similarly reduced by Se-exposure. Animals 
exposed for 24 hours to both Se and either the cholinergic agonist levamisole (Fig. 3A, middle 
panel), or the acetylcholinesterase (AChE) inhibitor aldicarb (Fig. 3A, lower panel), retained 
activity in all their muscles similar to controls (Fig. 3A, upper panel, mock-exposed animals at 
24 hours). The levamisole result was comparable to that previously reported for starved animals, 
reporter protein stability was maintained throughout the body, and suggests that stimulation of 
muscle ACh receptors prevented the loss of the β-galactosidase activity (Szewczyk et al., 2000). 
Aldicarb similarly stabilized the reporter protein expression throughout the animals after Se-
exposure, but this was different from the drug’s effect in starved animals where protein stability 
was only maintained in the anterior region (Szewczyk et al., 2000).  




 Since AChE inhibitors prevent breakdown of ACh at the synaptic cleft, the observation 
that aldicarb prevents protein breakdown in the muscles of Se-exposed animals suggests that 
reduced levels of ACh at the NMJ may contribute to the Se-induced movement deficits. To test 
this theory, Se-exposed animals were tested for resistance to aldicarb-induced paralysis. If ACh 
levels are reduced at the neuromuscular synapse, then Se-exposed animals treated with aldicarb 
would be expected to paralyze slower than mock-exposed animals, similar to what has been 
classically observed with aldicarb treatment of mutant animals shown to have reduced levels of 
ACh (Mahoney et al., 2006). Because Se-exposure induces a range of assayable movement 
deficits (normal, backing, and paralyzed) (Morgan et al., 2010), the population used for the 
aldicarb assay was normalized by selecting animals that were backing deficient after 24 hours of 
exposure. These animals would be expected to already have sufficient Se-induced damage, but 
would not already be paralyzed prior to aldicarb treatment. Not surprisingly, the percentage of 
Se-exposed animals that exhibited aldicarb-induced paralysis was significantly less than that 
observed for the mock-exposed animals 90 and 120 minutes after being placed on aldicarb 
containing agar plates (Fig. 3B). Since nearly all WT animals are paralyzed within five hours in 
the presence of 0.5 mM aldicarb (Mahoney et al., 2006), we tested an additional AChE inhibitor, 
eserine salicylate. Animals treated with eserine salicylate did not paralyze or die after 24 hours of 
exposure although at the highest concentrations tested (100 and 1000 µM) they were observed to 
be marginally hyper-contracted and slower in movement (Fig. 3C, ■-H2O). Thus, animals could 
be exposed to both Se and an AChE inhibitor for 24 hours. When populations of animals were 
coincidentally exposed to Se and eserine salicylate, they showed significantly improved motility 
across most of the concentration range tested (Fig. 3C, ∆-5 mM Na2SeO3). These data together 
coupled with the levamisole data presented above (Fig. 1E-H) suggest that the damage due to Se-




exposure mimics behaviors that would be expected if muscles are experiencing reduced levels of 
ACh at the NMJ (Miller et al., 1996).  
3.4 Reductions in cholinergic muscle reception enhance selenium’s effect on movement.  
Postsynaptic cells at the NMJ in C. elegans contain three types of receptors, one ionotropic 
GABAA receptor (GABAR) composed of subunits encoded by the unc-49 gene, and two ACh 
receptors (AChRs) (Richmond and Jorgensen, 1999). One of the two AChRs is sensitive to 
nicotine (N-AChR) and is composed of subunits encoded by the acr-16 gene (Touroutine et al., 
2005). The second is levamisole sensitive (L-AChR) and composed of a multimer of three -
LEV-8, UNC-38, UNC-63) and two non- subunits (LEV-1, UNC-29) (Boulin et al., 2008). 
GAR-2, a muscarinic AChR (M-AChR) is expressed in motor neurons located along the ventral 
cord and is not expressed in muscles (Lee et al., 2000). Previous studies (Miller et al., 1996) 
suggested that animals responding normally to levamisole and resistant to aldicarb-induced 
paralysis do not have impaired ACh reception. Based on these studies and those presented thus 
far in this paper, we examined strains containing mutations in genes affecting ACh reception at 
the NMJ both pre- (gar-2) and post-synaptically (lev-1, unc-29, unc-38, unc-63), and the post-
synaptic GABAR (unc-49) for their resistance or sensitivity to Se-induced damage in order to 
estimate the site of the Se-induced effects. Because some of these mutant strains displayed 
defects in backwards movement (Hosono and Kamiya, 1991), animals were measured only for 
their ability to move forward as previously described (Morgan et al., 2010). Animals containing 
mutations in any of the levamisole-sensitive AChR subunits tested, lev-1, unc-29, unc-38,and 
unc-69, showed significantly greater sensitivity to Se-induced damage as indicated by a decrease 
in the percentage of Se-exposed animals moving forward normally while both the M- and N-
AChR mutant animals were no different from WT (Fig. 4A). Animals with a mutation in the unc-




49 GABAR were also significantly more sensitive to Se-exposure (Fig. 4A). Thus, Se seems to 
exert its greatest effect on movement behavior in those strains containing mutations affecting 
post-synaptic reception while the presynaptic GAR-2 M-AChR was not affected. Coupled with 
the anatomical observations that Se induced damage to neurons (Fig. 2E-J), but not muscles (Fig. 
2A-D), these data support the hypothesis that Se induces damage to the presynaptic motor 
neurons affecting the levels of ACh available to muscles. 
3.5 Pre-synaptic defect in acetylcholine release induces hypersensitive to selenium. 
Mutations in the unc-17 gene which encodes the vesicular ACh transporter (VAChT) (Alfonso et 
al., 1993) confer an uncoordinated-coiler phenotype with difficulty backing (Rand and Russell, 
1984) and resistance to aldicarb (Nguyen et al., 1995).  Although unc-17 mutants have normal 
ACh levels (Nguyen et al., 1995), their resistance to aldicarb suggests a reduction in ACh 
secretion.  Synaptobrevin proteins are part of the SNARE (soluble N-ethylmaleimide-sensitive-
factor attachment protein receptor) complex that is involved in fusion at the plasma membrane of 
neurotransmitter filled vesicles.  In C. elegans, the synaptobrevin protein is encoded by snb-1 
(Nonet et al., 1998).  The uncoordinated and aldicarb resistance phenotypes of the unc-17(e245) 
mutant are suppressed by the dominant snb-1(e1563) allele by presumably restoring secretion of 
ACh to near normal levels (Sandoval et al., 2006).  Because our cumulative data suggested that 
ACh levels at the NMJ were reduced after Se-exposure (Fig. 3 and 4A), we tested both the unc-
17(e245) and unc-17(e245);snb-1(e1563) strains for their sensitivity to the Se-induced motility 
deficits (Fig. 4B).   Animals with a mutation in the unc-17 gene only were significantly more 
sensitive to the Se-induced effects on movement (Fig. 4B) while the unc-17(e245);snb-1(e1563) 
was no different in its response than was the WT strain, N2 (Fig. 4B).  Hence, these data suggest 




that a reduction in ACh reception at the NMJ is sufficient to increase sensitivity to Se-exposure 
most likely due to decreases in presynaptic release of ACh. 
3.6 Glutathione requires GLRX-21 glutaredoxin to reduce Se-induced egg-laying defect.  
Egg-laying in C. elegans is a well-defined circuit involving eight neurons and 16 vulval and 
uterine muscles (White et al., 1986). Animals that are abnormal in egg-laying are termed egg-
laying defective (e.g. do not lay eggs either completely or at a slower rate than normal) (Trent et 
al., 1983) or egg-laying constitutive (e.g. lay eggs continuously without regard to normal 
inhibitory cues) (Bany et al., 2003). In studies of the progressive impairment of motility seen in 
animals exposed to high dose Se, we noted that Se-exposed animals retained late stage embryos, 
thus displaying an egg-laying defective (Egl-d) phenotype (Fig. 1H inset and 5B) that was not 
observed in mock-exposed animals (Fig. 1F inset and 5A). In order to definitively determine if 
high dose Se exposure caused a statistically significant effect on egg-laying, we measured the 
egg-laying rate (eggs laid/animal/hour) of age-synchronized WT adult animals growing on agar 
plates with or without Se for 1-6 hours (Fig. 5C). Under these conditions, Se-exposure reduced 
their overall egg-laying rate by 75% after 6 hours when compared to mock-exposed controls 
(Fig. 5C). Intriguingly, at the same 6 hour time point we had observed severe motility 
impairment (paralyzed or dead) in only 30% of the Se-exposed animals (Morgan et al., 2010). 
This implies that substantial and detectable amounts of damage to the egg-laying circuit must 
occur at a much earlier time point than damage to the motor circuit.  
 The application of exogenous serotonin has been demonstrated to stimulate egg-laying 
behavior through its direct action on serotonin receptors located on the egg-laying muscles (Shyn 
et al., 2003; Carre-Pierrat et al., 2006; Hobson et al., 2006). If exogenous application of serotonin 
could rescue the reduction in the egg-laying rate observed after Se-exposure (Fig. 5C), then it 




could be presumed that the primary site of the Se-induced damage to egg-laying lies primarily in 
the neurons controlling egg-laying. Conversely, if it did not rescue the egg-laying rate then 
muscles or both may be affected (Shyn et al., 2003). Therefore, in order to clarify the site of Se 
damage, exogenous serotonin was applied to age-synchronized adult WT populations exposed 
with or without Se for 6 hours (Table 2). Here it was found that serotonin was able to 
significantly increase the egg-laying rates of both populations of animals (Table 2). This data 
coupled with those of the levamisole studies presented above (Fig. 1E-H) suggest that Se-
exposure primarily induces damage to the neurons controlling the egg-laying process while 
sparing muscle function.  
 Previous studies have shown that the progressive Se-induced movement phenotype was 
affected by oxidative stress damage (Morgan et al., 2010). Based on this, we predicted that the 
Se-induced Egl-d phenotype was mediated similarly. To test this hypothesis WT animals were 
pretreated with the cellular antioxidant reduced glutathione (GSH) or mock-pretreated with water 
prior to being placed on culture plates with high dose Se, then scored for their egg-laying ability 
after six hours of Se-exposure  (Fig. 5D).  These studies found that Se-exposed animals 
pretreated with GSH had a significantly increased rate of egg-laying when compared to animals 
not pretreated with GSH prior to Se exposure (Fig. 5D) suggesting that Se induces oxidative 
stress not only on movement, but also on egg-laying behavior.   
 Glutaredoxins are well known GSH-dependent oxidoreductases that have been shown to 
utilize Se as a substrate (Wallenberg et al., 2010). We have previously shown that GLRX-21, one 
of the five worm glutaredoxins, mediates the protective effects of GSH on Se-induced lethality 
(Morgan et al., 2010).  Similarly, animals with a null mutation in glrx-21(tm2921) did not 
increase their egg-laying rate after Se exposure with GSH pretreatment (Fig. 5D). This 




observation is consistent with a role for the antioxidant GLRX-21 glutaredoxin in mediating the 





The range of tissue damage observed in various vertebrate species exposed to toxic levels of Se 
in their environment has shown that Se can induce necrotic changes in multiple organs and 
tissues including muscles and the nervous system (Koller and Exon 1986). The mechanisms 
mediating this observed tissue damage have begun to be defined in various model systems 
including C. elegans where it has recently been shown that Se induces oxidative stress capable of 
causing lethality and paralysis in a dose dependent manner (Morgan et al., 2010). Here we 
provide evidence that high dose Se exposure exerts this effect by inducing damage to and 
degeneration of cholinergic motor neurons affecting two essential behavioral phenotypes in C. 
elegans, locomotion and egg-laying (summarized in Fig. 6).  In addition, we present evidence 
that the GLRX-21 glutaredoxin is required in egg-laying for oxidative stress mediation by 
glutathione as was observed previously for lethality and movement (Morgan et al., 2010), and for 
protection from age-related cell loss of motor neurons   
4.2 Altered acetylcholine signaling a mechanism for selenium-induced toxicity in C. elegans. 
The observed reduction in egg-laying rates after Se-exposure described here, like the decreased 
locomotion rates previously described (Morgan et al., 2010), point to the neuromuscular system 
as a target for Se damage.  The ability of levamisole which acts on the post-synaptic side of the 




NMJ (Martin et al., 2005), to induce muscle contraction in Se-exposed animals (Fig. 6), and the 
observation that myosin and actin filaments in the body wall and egg-laying muscles appeared to 
be unaffected by Se-exposure suggested that Se does not directly damage muscles, but instead 
alters their responsiveness to cholinergic signaling.  This was supported by our observations that 
animals with mutations that altered cholinergic reception on muscles were more sensitive to Se’s 
effects on movement.   Although both the L-AChR and N-AChR are localized to muscles 
(Touroutine et al., 2005; Richmond and Jorgensen, 1999), this increased sensitivity was 
significant in strains containing mutations in the L-AChR subunits only (LEV-1, UNC-29, UNC-
38, UNC-63; Fig. 4A) and parallels previous studies in C. elegans that have demonstrated the 
function of the L-AChR has a greater impact on locomotion then does the N-AChR (Touroutine 
et al., 2005).   Interestingly, a reduction-of function mutation in the muscle GABAR encoding 
gene unc-49 (Richmond and Jorgensen, 1999) also demonstrated enhanced sensitivity to Se-
induced paralysis suggesting GABAergic signaling is potentially protective against Se-induced 
toxicity, and that disinhibition of signaling through some other pathway normally inhibited by 
UNC-49 function may potentiate Se-induced neurotransmission problems. Although these 
studies could not rule out the possibility that Se induces damage to sub-cellular muscle 
compartments (eg. mitochondria), a recent study examining mutations in genes affecting 
movement behavior suggested that these types of behavioral effects were least likely to result 
from sub-cellular muscle defects (Shephard et al., 2011).    
 High dose Se levels induced catabolism of a soluble cytosolic reporter protein expressed 
in muscle that has been shown previously to occur with impaired cholinergic signaling 
(Szewczyk et al., 2000; Corbett et al., 1982). This catabolism could be efficiently suppressed by 
either increasing cholinergic signaling through levamisole-induced AChR activation or by 




suppressing ACh breakdown at the NMJ with the AChE inhibitor aldicarb.  That the pattern of 
suppression observed with levamisole and aldicarb treatment of Se-exposed animals did not 
directly mimic that observed in starved animals where levamisole, but not aldicarb, was observed 
to completely suppress catabolism (Szewczyk et al., 2000) suggests that Se unlike starvation 
does not induce anterior-posterior distinctions, but rather causes a global decrease in the levels of 
ACh signaling measured within this assay.  Gene mutations which decrease cholinergic synaptic 
transmission are resistant to aldicarb-induced paralysis (Miller et al., 1996).   Similarly, animals 
which could not move backwards after suffering Se-induced damage were significantly more 
resistant to the paralyzing effects of aldicarb relative to control animals. That Se-damaged 
animals were slower to paralyze than their mock-exposed counterparts in the presence of the 
AChE-inhibitor aldicarb supports a hypothesis that exposures to high dose Se reduces the 
amount of ACh available at the NMJ (Fig. 6).  In addition, mutant animals with impaired 
synaptic release of ACh were more sensitive to the Se-induced loss of motility as demonstrated 
by the susceptibility of animals with a reduction-of-function mutation (e245) in the unc-17 gene 
which impairs vesicular loading of ACh (Alfonso et al., 1993).  Loss of GAR-2/M-AChR which 
has been shown to initiate a negative feedback loop on cholinergic motor neurons in response to 
increased levels of ACh (Dittman and Kaplan, 2008) did not increase the Se-induced movement 
defects.  This result is consistent with our hypothesis because loss of GAR-2 function which 
responds to increased levels of ACh at the NMJ should not affect movement if high dose Se-
exposure reduces ACh levels.  Together this evidence supports a neurotoxicity model in which 
high levels of Se-exposure in the environment directly cause loss of cholinergic signaling that 
results in the effects on motility observed and is consistent with previous studies suggesting that 




cholinergic signaling in C. elegans is altered by environmental Se exposure (Li et al., 2011), but 
provides more conclusive evidence.  
 
4.3 Direct evidence of motor neuron degeneration with toxic selenium exposure models 
neurodegenerative disease. 
In our examination of Se-exposed C. elegans adults, the cholinergic motor neurons in their 
ventral cords exhibited signs of neurodegeneration that included axonal beading, cellular 
swelling, and nuclear cytoplasmic boundary loss and fragmentation.  These changes bore striking 
similarities to the Se-induced neuronal pyknosis and necrosis observed in the ventral horns of 
pigs (Nathues et al., 2010; Panter et al., 1996), as well as the cellular blebbing of hepatocytes 
from rainbow trout exposed to SeMet (Misra et al., 2012).  Se-exposure resulted in a significant 
increase in the percentage of WT adult animals with motor neuron cell loss suggesting that the 
neurodegenerative processes observed in the Se-exposed worms lead to cell death.  This 
accumulation of degeneration and cell loss in the cholinergic motor neurons of the ventral cord 
most likely contributes to the increasing motility impairment observed over time with Se 
exposure (Morgan et al., 2010), a phenomenon that has been documented to occur in 
neurodegenerative disease models of ALS, Huntington’s and Parkinson’s Diseases from 
Drosophila, mice, and C. elegans (Estes et al. 2011; Tamura et al., 2011; Bonilla-Ramirez et al. 
2011; Chesselet  and Richter 2011; Kanning et al., 2010; Cao et al., 2010; Wang et al., 2009; 
Morley et al., 2002; Mangiarini et al., 1996). Additionally, the disruption of the orderly array of 
the presynaptic densities observed along the ventral cord after Se-exposure paralleled changes 
observed at the NMJ within the SOD1 mouse model of ALS (Fischer et al., 2004) further 
suggesting that the neurodegenerative process targeting cholinergic neurons initiated by Se 




toxicity is similar to changes observed during neurodegenerative disease processes that target 
motor neurons in other organisms.   
 
4.4 GLRX-21 glutaredoxin is required for preventing age-related loss of motor neurons.  
Although nerve cell integrity is generally well maintained during normal aging in comparison to 
other tissues, enhanced cellular stress is known to increase age-related neuronal cell death in C. 
elegans and other organisms (Takács-Vellai et al., 2006).  Intriguingly, we observed that mock-
exposed animals lacking the GLRX-21 protein were more likely than WT animals to be missing 
at least one cholinergic VC neuron at the 24 hour time point, suggesting that GLRX-21 protects 
against age-related neuron loss. This difference was most likely not developmental, or due to 
programmed cell death, since VC neuron loss was random rather than cell-specific. The base-line 
difference between WT and the glrx-21(tm2921) animals when not exposed to Se goes away by 
the 48 hour time point suggesting that compensatory antioxidant protective mechanisms might be 
activated in the absence of normal GLRX-21 function to prevent further neuron loss. If cellular 
protection against ROS is impaired in animals lacking GLRX-21, the additional oxidative stress 
provided by Se-exposure should again increase cell loss in the glrx-21(tm2921) animals versus 
WT. This was observed in the older glrx-21(tm2921) animals which showed an increased 
prevalence of cell loss over WT animals when examined at the 48 hour time point after Se-
exposure. Thus, GLRX-21 appears to be required both to mediate GSH oxidative stress relief, 
and to prevent age related ROS-induced cell loss in the cholinergic VC neurons.  
 
5. Conclusion  




We have demonstrated that exposure to high dose Se in the environment is sufficient to induce 
neuronal damage and cell loss and to alter cholinergic signaling in C. elegans. Although we have 
shown previously that the GLRX-21 protein was required to mediate the antioxidant effects of 
GSH, here we present evidence for a role in cell maintenance of cholinergic motor neurons under 
oxidative stress. Intriguingly, a GLRX-21 ortholog, glutaredoxin 2 has been shown to prevent 
aggregation of mutant SOD1 in a mouse model of ALS, a neurodegenerative disease affecting 
cholinergic motor neurons (Ferri et al., 2010). The association between high dose environmental 
Se and the increased risk of ALS within exposed populations (Vinceti et al., 2010), coupled with 
the data presented suggests that an ALS model based on Se-induced oxidative stress may be an 
alternative and complimentary model to those based on SOD1 for examining the connections 
between oxidative stress and ALS pathology.   
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Figure Legends 
Figure 1. Selenium causes paralysis independent of muscle function.   




Animals paralyzed by high dose Se-exposure responded normally to treatment with levamisole, 
an anthelmintic which functions as a cholinergic agonist and induces muscle contraction in C. 
elegans. “+” indicates exposure to 5 mM Na2SeO3 while “-” indicates mock-exposure to water 
only. Scale bars (E-H, including insets), 50 µm.  
(A-D) Nearly all mock-exposed adult WT animals leave a 1 cm diameter circle after 5 minutes 
(compare A to B) while paralyzed Se-exposed adults do not (compare C to D).  
(E-H) When treated with the levamisole, both mock- and Se-exposed adults were observed to 
hyper-contract (compare E to F, and G to H, respectively) and lay eggs (F and H, insets). Late 
stage embryos were observed in the eggs released by the Se-exposed animals only (H, inset)  
 
Figure 2. Neurons, but not muscles appear structurally damaged by selenium.  
In adult hermaphrodites, exposure to high dose Se damages cholinergic motor neurons in the 
ventral cord and those required for egg-laying, but does not affect muscles. “*” = vulva (C-H). 
“Arrowheads” = VC neurons, “arrows” = HSNs, white color indicates normal and black 
indicates damaged or missing (E-H). “+” and “-”, and scale bars are as in Fig. 1, except inset 
scale bars = 5 µm.  
(A-B) Animals expressing an integrated myosin-GFP translational fusion protein (MYO-3::GFP) 
were grown for 48 hours “+” or “-” Se. The regular linear pattern of the MYO-3::GFP in the 
head (A) was not grossly altered by Se exposure (B).  
(C-D) Similarly, in phalloidin staining of F-actin no apparent structural differences were 
observed between mock- (C) or Se-exposed animals (D), as shown in the vulval region.  




(E-H) Nearly all mock-exposed WT animals expressed the Pida-1::gfp transgene in all six VC 
neurons and the two HSNs (E) while Se-exposed animals were significantly more likely (Table 
1) to have lost GFP expression in one or more VC neurons (F).  400x, mock-exposed animals  
were observed to exhibit normal cellular morphology in their VC neurons (G) and HSNs (G, 
inset) while neurons from Se-exposed animals showed evidence of neurodegeneration, including 
nuclear swelling (H; VC neuron), nuclear fragmentation (H, inset; HSN), and axonal beading (H, 
double arrowhead lines). (I-J) Presynaptic densities were visualized using an unc-4::snb-1::GFP 
reporter construct that expresses a fusion of GFP and the C. elegans synaptobrevin protein, SNB-
1 in a subset of cholinergic motor neurons in the ventral cord.  A regular pattern of expression 
was observed after 24 hours in mock-exposed adult animals (I). This pattern was disrupted in a 
significant percentage of the Se-exposed population (J).  
 
Figure 3. Selenium alters cholinergic signaling.  
Pharmacological agents that increase cholinergic signaling at the NMJ, either by preventing 
breakdown of ACh (aldicarb and eserine salicylate) or through activating AChRs on muscles 
(levamisole), reduced movement deficits caused by high dose Se-exposure and prevented Se-
induced loss of a soluble muscle protein, but could not induce a time dependent increase in 
paralysis suggesting that ACh levels at the NMJ are decreased after Se-exposure.  
(A) Animals expressing a myosin::lac-z reporter were histochemically stained for β–
galactosidase activity. Reporter activity was reduced in muscles of Se-exposed, but not mock-
exposed animals at 24 and 48 hours (Upper Panel). After 24 hours exposure to Se, levamisole 
(Mid Panel) and aldicarb (Lower Panel) treatment both suppressed protein degradation in muscle 




cells. Controls for the Se-exposed worms at 0 hours were not determined (ND) because they 
were no different from mock-exposed. “+” and “-” are as in Fig. 1. 
(B) The percentage of adult WT (N2) animals paralyzed by aldicarb gradually increases over 
time. A significant reduction was observed for the Se-exposed populations (∆) that were backing 
deficient prior to aldicarb treatment as compared to mock-exposed populations (■) at <90 
minutes. Data was reported for each time point as the average percentages of twenty paralyzed 
animals with six repetitions (n = 120). Error bars = + SEM.  
* p =3.2 x 10
-17
, by two-way ANOVA, comparing Se-exposed to mock-exposed animals at the 
same time points after aldicarb treatment; post-hoc analysis by Student’s t-test.  
(C) Populations of animals exposed to a concentration range (∆, 0.1 to 1000 m) of eserine 
salicylate and Se show a dose dependent increase in the percentage of animals that are motile 
(move both forwards and backwards) which is significantly different when compared to the Se-
exposed controls (∆, 0 m). Although animals not exposed to Se, but treated with the two highest 
concentrations of eserine salicylate  (■, 100 and 1000 µM) were observed to move slower than 
the water only controls (■, 0 µM), they were not significantly different (p > 0.05 comparing 100 
and 1000 µM eserine salicylate with water).  
*p = 1.4 x 10
-2
 (one-way ANOVA, comparing Se-exposed and drug treated animals to Se-
exposed only animals, post-hoc analysis by Student’s t-test). Error bars = +SEM. 
 
Figure 4. Presynaptic cholinergic release is altered by selenium.  




Mutations in some genes which reduce either post-synaptic muscle reception (lev-1, unc-29, unc-
38, unc-63) or affect ACh release from motor neurons (unc-17) adversely alter forward 
movement behavior in response to high dose Se exposure. 
(A) Reduction- or loss-of-function mutations in some of the C. elegans AChRs (lev-1, unc-29, 
unc-38, unc-63) and one GABAR (unc-49), but not others (acr-16, gar-2), conferred additional 
sensitivity to Se (black bars) when compared to WT animals as indicated by a decrease in the 
percentage of animals within each population that were able to move forward; Black bars = 
mock-exposed controls. Each graph bar represents an average of four plates with twenty animals 
each repeated three to four times (average n/graph bar = 300); error bars = +SEM.  “non-α” and 
“α” refer to the subtypes of the L-AChR. 
*p = 2.8 x 10
-20
, by one-way ANOVA comparing the Se-exposed mutant strains to the Se-
exposed WT strain, post-hoc analysis was by Student’s t-test.  
(B) Populations of animals with a reduction-of-function mutation (e245) in the C. elegans 
VAChT, unc-17 had significantly less normal forward movement in comparison to WT 
populations of animal after 24 (black bars) and 48 (white bars) hours of Se exposure. A dominant 
mutation (e1563) in the gene for the vesicle-associated membrane protein, synaptobrevin (snb-1) 
was able to suppress this unc-17(e245) Se-induced phenotype such that there was no significant 
difference (NS) between populations of the unc-17;snb-1 double mutant strain when compared to 
WT populations exposed for the same amount of time (Student’s t-test). Since animals with the 
unc-17(e245) mutation do not normally move backwards, forward movement only was scored 
such that direct comparisons of the three strains could be made. Each graph bar represents at 
least five plates of twenty animals (n > 100) of each genotype (WT, unc-17, unc-17;snb-1) which 




were scored at 24 and 48 hours to determine the percentage of animals within each population 
expressing each phenotype; error bars = +SEM.  
*p =6.8 x 10
-7
 (two-way ANOVA comparing unc-17 to both WT and unc-17;snb-1 across 
phenotypes and time, post-hoc analysis was by Student’s t-test).   
 
Figure 5. Decreased egg-laying rates after selenium-exposure.  
Animals exposed to high dose Se were not only observed to retain late stage embryos, but to 
reduce their egg-laying rate overtime, a phenomena that appeared to be partially mediated 
through oxidative stress-induction. 
 (A-B) Adult animals expressing GFP under the control of the promoter for the pan-neuronal 
expression gene, unc-119  and maintained continuously in the presence of an adequate food 
supply do not normally retain embryos past the multicellular stages (A) although late stage 
embryos (two-fold and beyond) were observed after only 24 hours exposure to Se under the 
same conditions (B). “+” and “-”, and scale bars are as in Fig. 1.  
(C) The egg-laying rate (#eggs laid/animal/hour) of WT animals was reduced after six hours of 
exposure to Se as compared to mock-exposed animals (H2O). Each bar graph represents the 
average progeny from 30 animals (three plates of ten animals each); error bars = +SEM.  
* p = 1.9 x 10
-2
, comparing Se-exposed to mock-exposed animals at the same time point, 
Student’s t-test (two-tailed, unequal variance).  
(D) The Se-induced reduction in the egg-laying rate was mediated by oxidative stress since 
treatment with the cellular antioxidant glutathione (GSH) was able to partially rescue this 
phenotype. In addition, the glrx-21(tm2921) null mutant could not be rescued by the GSH 
pretreatment.  NS, not significant (Student’s t-test).  




* p = 4.1 x 10
-13
-WT and p = 3.8 x 10
-14
-glrx-21 (one-way ANOVA comparing across conditions 
within strains).  
** p = 1.6 x 10
-2
 -WT and p = 5.2 x 10
-4
 -glrx-21, comparing “Se-exposed only” to “Se-exposed 
pretreated with GSH” animals within the same strain (Student’s t-test). 
 
Figure 6.  Summary: Motor neuron signaling to muscles is altered by selenium-induced 
oxidative stress.   
Reduced glutathione (GSH) normally prevents reactive oxygen species (ROS) from damaging 
cells.  Excess selenium (Se) from the environment can both increase the formation of ROS and 
decrease the pool of GSH, thus inducing motor neuron (yellow) degeneration and impairing the 
vesicular acetylcholine transporter (VAChT) activated release of acetylcholine (ACh, orange hat) 
from synaptic vesicles (green circles).  The reduction in ACh available to muscles reduces 
contractility, but does not affect the function of muscles since exogenous application of the 
pharmaceutical aldicarb induces muscle paralysis by artificially increasing ACh in the 
neuromuscular junction (space between muscle and neuron).  Aldicarb inhibits the action of the 
enzyme acetylcholinesterase (AChE) which normally functions to inactivate ACh by breaking it 
down into its constituent parts choline (orange circle) and acetate (orange rectangle).  In addition, 
the levamisole-sensitive ACh receptors (L-AChR) still respond by causing muscle hyper-
contraction when the AChR agonist levamisole is exogenously applied.  ChAT = choline acetyl 
transferase. 
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Table 1. Effects of Se-exposure on the cholinergic VC motor neurons. 
 










% population per strain with 







 [(-) to (+)] [WT to glrx] 
WT 24 hours 1.6 ± 0.1 (306) 50.2 ± 15.4  (581) 1.1 x 10
-3
(WT) 3.5 x 10
-2
(-) 
glrx 6.0 ± 0.3 (150) 41.5 ± 9.4 (316) 2.8 x 10
-2
(glrx) 0.40 (+) 
WT 48 hours 3.3 ± 0.3 (305) 38.1 ± 11.4 (536) 2.1 x 10
-3
(WT) 0.33 (-) 
glrx 3.8 ± 1.4 (105) 58.3 ± 3.7 (177) 4.2 x 10
-2





  p value is determined by comparing the conditions or strains at the top of the column within 
the condition or strain in parenthesis following the p value. 
b
 WT (wild-type) = N2; glrx = glrx-21(tm2921) 
c
 Se(+): includes approximately equal ratios of normal forward moving and paralyzed animals; 
averages are standardized by subtracting the average of baseline control animals [Se(-)] for 
each experimental set from the corresponding Se-exposed set. 
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Eggs from three plates containing three adult animals each (progeny from nine animals) per  
 condition [H2O or 5HT, and Se(-) or Se(+)]. 
b 
p value is determined by comparing the conditions at the top of the column within the 
condition in parenthesis following the p value.  
c  
Final serotonin concentration on agar plates = 3 mg/ml.  
 
 
 #Eggs laid/animal/hour ±SEM 
a
 p values 
b 
Se Water (H2O) Serotonin (5HT)
c
  [H2O to 5HT] [(-) to (+)] 
- 3.9 ± 0.3 15.5 ± 0.7 8.0 x 10
-4
 (-) 6.4 x 10
-3 
(H2O) 
+ 1.8 ± 0.2 11.1 ± 0.5 1.1 x 10
-3
 (+) 7.6 x 10
-3 
(5HT) 
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